Skip to main content
Jeffrey Glenn, MD, Gastroenterology, Palo Alto, CA, Stanford Health Care

JeffreyGlennMD

Gastroenterology • Palo Alto, CA

Associate Professor, Medicine - Gastroenterology & Hepatology, Stanford University Medical Center

Join to view full profile

Dr. Glenn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Glenn's full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 1995 - 1998
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1993 - 1996
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - 2026
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2008

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Pegylated Interferon Lambda May Prevent Severe COVID-19
    Pegylated Interferon Lambda May Prevent Severe COVID-19February 13th, 2023
  • New Injected Drug May Prevent Severe COVID
    New Injected Drug May Prevent Severe COVIDFebruary 9th, 2023
  • The Prognosis for Telehealth
    The Prognosis for TelehealthMay 23rd, 2022

Grant Support

  • The Pip2-Virus Interface And PI 4-Kinase: Novel Biology And Validation TargetsNational Institute Of Allergy And Infectious Diseases2012
  • HCV NS4B: Translating Molecular Virology Into Novel Antiviral TherapiesNational Institute Of Allergy And Infectious Diseases2010–2012
  • Advancing Clemizole For Hepatitis C: Towards A Pre-Ind PackageNational Institute Of Allergy And Infectious Diseases2010
  • Towards The Creation Of Hcv-Resistant Liver Cells For TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
  • HCV Ns5a: Molecular Virology And Antiviral TargetNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2010
  • Novel Antiviral Targets In Hepatitis C Virus NS4BNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2007

Hospital Affiliations

Dr. Jeffrey Glenn, Dr. Jeffrey Glenn, MD, Dr. J Glenn